Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.
The Food and Drug Administration has approved a new drug for treating bowel diseases made by Ironwood Pharmaceuticals, the agency said Thursday.
The syndicated health program "The Dr. Oz Show" last week featured Jarrow Formulas' Carnosine supplement, Jarrow announced.
The Food and Drug Administration has approved a drug made by Shire for a rare autoimmune condition, the agency said.
British drug maker Shire again is trying to win approval for a hereditary angioedema drug that the Food and Drug Administration had previously declined to approve.